These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9225755)

  • 21. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.
    Bowyer JF; Clausing P; Schmued L; Davies DL; Binienda Z; Newport GD; Scallet AC; Slikker W
    Brain Res; 1996 Mar; 712(2):221-9. PubMed ID: 8814896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
    Hanna DM; Tadros MG; Khalifa AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():36-51. PubMed ID: 25689821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.
    Lastres-Becker I; Fezza F; Cebeira M; Bisogno T; Ramos JA; Milone A; Fernández-Ruiz J; Di Marzo V
    Neuroreport; 2001 Jul; 12(10):2125-9. PubMed ID: 11447320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.
    Kumar P; Kalonia H; Kumar A
    Eur J Pharmacol; 2012 Jan; 674(2-3):265-74. PubMed ID: 22154757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
    Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
    Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.
    Lee WT; Chang C
    Prog Neurobiol; 2004 Feb; 72(2):87-110. PubMed ID: 15063527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive.
    Ishida K; Shimizu H; Hida H; Urakawa S; Ida K; Nishino H
    Neuroscience; 2004; 125(3):633-44. PubMed ID: 15099677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats.
    Mahdy HM; Tadros MG; Mohamed MR; Karim AM; Khalifa AE
    Neurochem Int; 2011 Nov; 59(6):770-8. PubMed ID: 21827809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.
    Milutinović A
    Bosn J Basic Med Sci; 2016 Nov; 16(4):261-267. PubMed ID: 27289244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.
    Mealer RG; Subramaniam S; Snyder SH
    J Neurosci; 2013 Feb; 33(9):4206-10. PubMed ID: 23447628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats.
    Menze ET; Tadros MG; Abdel-Tawab AM; Khalifa AE
    Neurotoxicology; 2012 Oct; 33(5):1265-75. PubMed ID: 22850463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
    Kodsi MH; Swerdlow NR
    Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.
    Borlongan CV; Koutouzis TK; Freeman TB; Cahill DW; Sanberg PR
    Brain Res; 1995 Oct; 697(1-2):254-7. PubMed ID: 8593585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of repetitive spreading depression on neuronal damage in juvenile rat brain.
    Jafarian M; Rahimi S; Behnam F; Hosseini M; Haghir H; Sadeghzadeh B; Gorji A
    Neuroscience; 2010 Aug; 169(1):388-94. PubMed ID: 20438812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain.
    Appel NM; Rapoport SI; O'Callaghan JP
    Synapse; 1997 Apr; 25(4):350-8. PubMed ID: 9097394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profilin-2 increased expression and its altered interaction with β-actin in the striatum of 3-nitropropionic acid-induced Huntington's disease in rats.
    Chakraborty J; Pandey M; Navneet AK; Appukuttan TA; Varghese M; Sreetama SC; Rajamma U; Mohanakumar KP
    Neuroscience; 2014 Dec; 281():216-28. PubMed ID: 25255934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats.
    Dhadde SB; Nagakannan P; Roopesh M; Anand Kumar SR; Thippeswamy BS; Veerapur VP; Badami S
    Biomed Pharmacother; 2016 Feb; 77():52-8. PubMed ID: 26796265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.